头颈癌放疗后下颌骨放射性骨坏死NTCP预测模型:大样本观察队列
该研究基于2005—2015年接受放(化)疗的1259例头颈癌患者,开发并验证了预测下颌骨放射性骨坏死(ORN)的多变量临床/剂量NTCP模型。多变量分析确定下颌骨D30%和放疗前拔牙为ORNI-IV与ORNIV的独立预测因子,验证集AUC分别为0.75和0.82。结果提示下颌骨接受≥35 Gy的容积低于30%时ORNI-IV风险低于5%。
要点
- 下颌骨D30%和放疗前拔牙是ORN的独立预测因子。
- ORNI-IV与ORNIV模型验证集AUC分别为0.75和0.82。
- 下颌骨接受≥35 Gy容积低于30%时ORNI-IV风险低于5%。
核心结论
- 基于下颌骨D30%和放疗前拔牙的NTCP模型可预测头颈癌放疗后ORNI-IV和ORNIV。
- 下颌骨接受≥35 Gy的容积低于30%时ORNI-IV风险低于5%。
研究设计与样本
- 纳入2005—2015年接受放(化)疗的头颈癌患者,随机分为训练集(70%)和独立测试集(30%)。
- 在训练集中采用Bootstrap前向变量选择筛选预测因子,最终模型在保留测试子集中验证。
主要发现
- 1259例患者中13.7%(173例)发生任何级别ORN(ORNI-IV主要终点),5%(65例)发生ORNIV(次要终点)。
- 单变量模型中下颌骨所有剂量和体积参数均与ORN发生显著相关。
- 多变量分析确定D30%和放疗前拔牙为ORNI-IV和ORNIV最佳NTCP模型的独立预测因子。
- ORNI-IV模型AUC为0.78(验证集AUC 0.75 [0.69-0.82]),ORNIV模型AUC为0.81(验证集AUC 0.82 [0.74-0.89])。
关键数值与推荐
- 下颌骨接受≥35 Gy的容积低于30%时ORNI-IV风险低于5%。
临床怎么用
- 可利用下颌骨D30%和放疗前拔牙信息识别ORN高风险患者,改进ORN预防与管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Osteoradionecrosis (ORN) of the mandible represents a severe, debilitating complication of radiation therapy (RT) for head and neck cancer (HNC). At present, no normal tissue complication probability (NTCP) models for risk of ORN exist. The aim of this study was to develop a multivariable clinical/dose-based NTCP model for the prediction of ORN any grade (ORNI-IV) and grade IV (ORNIV) after RT (±chemotherapy) in patients with HNC. METHODS AND MATERIALS: Included patients with HNC were treated with (chemo-)RT between 2005 and 2015. Mandible bone radiation dose-volume parameters and clinical variables (ie, age, sex, tumor site, pre-RT dental extractions, chemotherapy history, postoperative RT, and smoking status) were considered as potential predictors. The patient cohort was randomly divided into a training (70%) and independent test (30%) cohort. Bootstrapped forward variable selection was performed in the training cohort to select the predictors for the NTCP models. Final NTCP model(s) were validated on the holdback test subset. RESULTS: Of 1259 included patients with HNC, 13.7% (n = 173 patients) developed any grade ORN (ORNI-IV primary endpoint) and 5% (n = 65) ORNIV (secondary endpoint). All dose and volume parameters of the mandible bone were significantly associated with the development of ORN in univariable models. Multivariable analyses identified D30% and pre-RT dental extraction as independent predictors for both ORNI-IV and ORNIV best-performing NTCP models with an area under the curve (AUC) of 0.78 (AUCvalidation = 0.75 [0.69-0.82]) and 0.81 (AUCvalidation = 0.82 [0.74-0.89]), respectively. CONCLUSIONS: This study presented NTCP models based on mandible bone D30% and pre-RT dental extraction that predict ORNI-IV and ORNIV (ie, needing invasive surgical intervention) after HNC RT. Our results suggest that less than 30% of the mandible should receive a dose of 35 Gy or more for an ORNI-IV risk lower than 5%. These NTCP models can improve ORN prevention and management by identifying patients at risk of ORN.
引用
- van Dijk LV, Abusaif AA, Rigert J, et al. Normal Tissue Complication Probability (NTCP) Prediction Model for Osteoradionecrosis of the Mandible in Patients With Head and Neck Cancer After Radiation Therapy: Large-Scale Observational Cohort. Int J Radiat Oncol Biol Phys. 2021. PMID: 33965514. doi:10.1016/j.ijrobp.2021.04.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。